摘要
环氧化酶 2在肺癌中有较高表达 ,并在肺癌的发生发展中起重要作用。环氧化酶 2可能通过促进血管的新生 ,打破机体的免疫平衡 ,参与肺癌的发生发展。
出处
《国外医学（生理病理科学与临床分册）》
2004年第5期422-424,共3页
Foreign Medical Sciences(Pathophysiology and Clinical Medicine)
参考文献18
-
1Soslow RA, Dannenberg AT, Rush D, et al. COX-2 expressed in human pulmonary, colonic, and mammary tumors [ J ]. Cancer,2000, 89(12) :2637-2645.
-
2Yukio H, Tomoyuki Y, Yuko H, et al. Increased cyclooxygenase-2( COX-2 ) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung [ J ]. Lung Cancer. 2000. 30:73-81.
-
3Husturk S,Kemp B,Kalapurakal SK, et al. Exprssion of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma [J]. Cancer, 2002, 94(4) :1023-1031.
-
4Elbayoumy K, latropoulos M, Amin S, et al. Increased expression of cyclooxyugenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4 - (methylnitrosamino) -4- ( 3-pyridyl ) -1 -butanone :the impact of a high-fat diet[J]. Cancer Res, 1999, 59(7) : 1400-1430.
-
5Wardlaw SA, Nikula R J, Kracko DA, et al. Cyelooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse straines and in premalignant lesions [ J]. Carcinogenesi,2000, 21(7): 1371-1377.
-
6Williams CS, Tsujii M, Reese J,et al. Host cyclooxygenase-2 modulates carcinoma growth [J]. Clin Inves, 2000, 105 ( 11 ) : 1589-1594.
-
7Masferrer JL,Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors [ J ]. Cancer Res,2000, 60:1306-1311.
-
8Pan MR, Chuang LY, Hung WC. Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells[J]. FEBS Lett,2001, 508(3 ) :365-368.
-
9Lin MT, Lee RC, Yang PC, et al. Cyclooxgenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1. 0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway [ J]. J Biol Chem, 2001, 276 ( 52 ) :48997-49002.
-
10Saha D, Datta PK, Sheng H,et al.Synergistic induction of cyclooxygenase-2 by transforming growth factor-betal and epidermalgrowth factor inhibits apoptosis in epithelial cells [ J ]. Neoplasi,1999,1 (6) :508-517.
同被引文献40
-
1徐刚,王兴鹏.环氧合酶-2抑制剂——一种新的肿瘤治疗增敏剂[J].国外医学（内科学分册）,2004,31(11):495-499. 被引量：4
-
2刘莹,朱祖安,费素娟.COX-2 iNOS及VEGF在胃不典型增生胃癌中的表达及其意义[J].中国肿瘤临床,2005,32(8):428-430. 被引量：9
-
3刘俊茹,齐凤英,左连富,李丽,张玉军,郭建文,刘江惠.尼美舒利对人食管癌Eca-109细胞凋亡及Survivin和Caspase-3表达的影响[J].中国肿瘤临床,2006,33(1):16-19. 被引量：9
-
4费素娟,陈光侠.尼美舒利抑制结肠癌细胞增殖及转移的机制[J].中国肿瘤临床,2006,33(9):497-499. 被引量：6
-
5郑惠如,金美玲,蔡映云.环氧化酶-2抑制剂在肺癌治疗中的研究进展[J].国际呼吸杂志,2007,27(16):1268-1271. 被引量：1
-
6Swamy MV,Herzog CR,Rao CV.Inhibition of COX -2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53[J].Cancer Res,2003 ;63 (17):5239-5242
-
7Hung WC,Chang HC,Pan MR,et al.Induction of P27(KIP1)as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells[J].Mol Pharmacol,2000;58(6):1398-1403
-
8Liu LT,Chang HC,Chang LC,et al.Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer[J].Oncogene,2002 ;21(54):8347-8350
-
9Klenke FM,Gebhard MM,Ewerbeck V,et al.The selective Cox -2 inhibitor celecoxib suppresses angiogenesis and growth of secondary bone tumors:An intravital microscopy study in mice[J].BMC Cancer,2006;6(9):1-8
-
10Masferrer JL,Leahy KM,Koki AT,et al.Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors[J].Cancer Res,2000;60:1306-1311
二级引证文献5
-
1张郜晨茜,舒琦瑾.南方红豆杉水提物抑制HGF/MET/PI3K/AKT信号通路克服阿法替尼耐药的体外研究[J].中华中医药杂志,2019,34(5):2140-2145. 被引量：5
-
2何驰宇,曹君.南方红豆杉水提物在肿瘤中的研究进展[J].浙江临床医学,2019,21(12):1729-1731. 被引量：1
-
3杨洋,苏晓萍,朱婧,梁奇,陈琴华,杨光义.红豆杉抗肿瘤活性成分及机制研究进展[J].职业与健康,2021,37(13):1859-1863. 被引量：5
-
4柯存,王帅.固本消瘤方联合靶向药物治疗非小细胞肺癌的临床观察[J].中国中医药科技,2022,29(1):137-139. 被引量：1
-
5张俊红.固本消瘤加减方联合阿帕替尼对不可切除的非小细胞肺癌的疗效[J].河南医学研究,2023,32(10):1861-1865.
-
1邢健,鲁光,刘国强,徐敏,赵霞,韩芳,王椋,丁慧芳.多发性骨髓瘤患者骨髓中Treg/Th17细胞失衡研究[J].中国实验血液学杂志,2014,22(5):1321-1325. 被引量：9
-
2李莉娟,张连生.细胞免疫治疗的前景与挑战[J].医院与医学,2014,2(1):68-70.
-
3张意兰.胰腺癌化疗后应用DC-CIK细胞对免疫平衡的影响及临床疗效研究[J].中国现代医学杂志,2014,24(9):42-45. 被引量：8
-
4陈旭艳,李婉祺,曾寰,黄晓鹭.恶性肿瘤患者外周血T淋巴细胞亚群的测定及临床意义[J].宁夏医学杂志,1998,20(6):367-368.
-
5周清华,刘坚,刘伦旭,石应康,赵雍凡,蒋光亮,杨振华.肺癌病人手术前后T淋巴细胞亚群的动态研究[J].华西医学,1994,9(4):482-485. 被引量：2
-
6许祥裕,徐立春,丁树标,吴明生,倪庆,缪培荣,徐芳,伏文均,童鲲.白细胞介素－2激活的肿瘤浸润淋巴细胞治疗晚期胃癌的临床观察[J].中华消化杂志,1995,15(3):136-139. 被引量：5
-
7贾蓓,刘建宁,张岁,马文波,柳立平.DC-CIK对肝癌患者免疫平衡的影响及临床疗效研究[J].河北医科大学学报,2016,37(4):440-444. 被引量：6
-
8周强,伍烽,朱学强,张军,李莉,王智彪.高强度聚焦超声治疗对乳腺癌细胞表达IL-6及IL-10的影响[J].肿瘤,2006,26(6):543-546. 被引量：9
-
9任莉莉,邓春艳,蒋锦杏,俞丽娜,齐晖,邙建波.细胞免疫治疗对乳腺癌患者Treg细胞表达的影响[J].山西医科大学学报,2015,46(7):672-675. 被引量：7
-
10李清靖,单保恩,李宏,苏景伟,张超,李巧霞.胃癌患者Th17/Treg细胞失衡的研究[J].中国全科医学,2015,18(29):3596-3600. 被引量：14
